000			02037nam a2200457 i 4500
001			ocn679940967
003			OCoLC
005			20190831111939.0
006			m o d f
007			cr bn||||||ada
008			101107s1993 mdua ob f000 0 eng c
019			_a623085369
040			_aOCLCE _beng _erda _epn _cOCLCE _dOCLCQ _dOCLCF _dOCLCQ _dOCLCO _dOCL _dOCLCQ _dGILDS _dOCLCO _dOCLCA _dGPO _dMvI
042			_adlr _apcc
043			_an-us---
074			_a0831-C-12 (online)
086	0		_aHE 20.3965:131 _zHE 20.8216:131
099			_aHE 20.3965:131
245	0	0	_aImpact of prescription drug diversion control systems on medical practice and patient care / _ceditors: James R. Cooper [and three others].
264		1	_aRockville, MD : _bU.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute on Drug Abuse, _c1993.
300			_a1 online resource (xi, 343 pages) : _billustrations.
336			_btxt
337			_bc _2rdamedia
338			_bcr _2rdacarrier
490	1		_aNIDA research monograph ; _v131
490	1		_aNIH publication ; _vno. 93-3507
504			_aIncludes bibliographical references.
500			_aCRDP Program record.
588			_aDescription based on online resource, PDF version; title from title page (NIDA, viewed April 3, 2019).
650		0	_aMedication abuse _zUnited States.
650		0	_aDrugs _xPrescribing _zUnited States.
650		7	_aMedication abuse. _2fast _0(OCoLC)fst01432065
651		7	_aUnited States. _2fast _0(OCoLC)fst01204155
700	1		_aCooper, James Richard, _d1943- _eeditor.
710	2		_aNational Institute on Drug Abuse, _eissuing body.
776	0	8	_iPrint version: _tImpact of prescription drug diversion control systems on medical practice and patient care _w(DLC) 93231210 _w(OCoLC)28528628
830		0	_aNIDA research monograph ; _v131.
830		0	_aNIH publication ; _vno. 93-3507.
856	4	0	_uhttps://purl.fdlp.gov/GPO/gpo118888
949			_aBEV _bFed Docs
999			_c285670 _d285670